Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-03 6:26 pm Purchase | 2024-12-31 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 6,903,749 13.500% | 2,468,215 (+55.65%) | Filing History |
| 2024-11-14 4:49 pm Purchase | 2024-09-30 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 4,573,746 9.990% | 1,858,111 (+68.42%) | Filing History |
| 2024-10-01 4:15 pm Purchase | 2024-09-27 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 4,435,534 9.800% | 146,341 (+3.41%) | Filing History |
| 2024-05-17 5:13 pm Purchase | 2024-05-16 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 4,289,193 11.200% | 1,492,915 (+53.39%) | Filing History |
| 2024-03-22 6:24 pm Purchase | 2024-03-20 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,796,278 7.500% | 352,039 (+14.40%) | Filing History |
| 2024-02-14 2:24 pm Purchase | 2023-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 2,715,635 9.990% | 1,728,424 (+175.08%) | Filing History |
| 2023-09-26 4:16 pm Purchase | 2023-09-25 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,444,239 11.300% | 80,906 (+3.42%) | Filing History |
| 2023-07-06 4:44 pm Purchase | 2023-06-30 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,363,333 13.600% | 81,406 (+3.57%) | Filing History |
| 2023-04-19 4:24 pm Purchase | 2023-03-31 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,281,927 17.500% | 78,214 (+3.55%) | Filing History |
| 2023-02-14 12:23 pm Purchase | 2022-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | ARMISTICE CAPITAL LLC | 987,211 9.990% | 987,211 (New Position) | Filing History |
| 2023-01-13 4:13 pm Purchase | 2023-01-05 | 13D | Checkpoint Therapeutics, Inc. CKPT | Fortress Biotech Inc. FBIO | 2,203,713 19.300% | 2,203,713 (New Position) | Filing History |
| 2021-05-07 5:09 pm Purchase | 2021-04-30 | 13G | Checkpoint Therapeutics, Inc. CKPT | BlackRock Inc. BLK | 348,761 4.800% | 24,702 (+7.62%) | Filing History |
| 2021-02-16 09:56 am Sale | 2020-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | CVI Investments, Inc. | 63,696 1.000% | -293,447 (-82.17%) | Filing History |
| 2021-02-02 3:13 pm Purchase | 2020-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | BlackRock Inc. BLK | 324,060 5.300% | 179,974 (+124.91%) | Filing History |
| 2021-01-07 09:18 am Sale | 2020-12-31 | 13G | Checkpoint Therapeutics, Inc. CKPT | SABBY MANAGEMENT, LLC | 0 0.000% | -357,143 (Position Closed) | Filing History |
| 2020-09-25 10:08 am Purchase | 2020-09-17 | 13G | Checkpoint Therapeutics, Inc. CKPT | CVI Investments, Inc. | 357,143 5.500% | 357,143 (New Position) | Filing History |
| 2020-09-18 10:10 am Purchase | 2020-09-18 | 13G | Checkpoint Therapeutics, Inc. CKPT | SABBY MANAGEMENT, LLC | 357,143 11.000% | 357,143 (New Position) | Filing History |